October 14, 2010 – A new round of equity financing will help launch the LipiScan IVUS Coronary Imaging System in the United States. InfraReDx raised $21 million to launch the first system to combine intravascular ultrasound (IVUS) with the company’s near infrared (NIR) spectroscopy.
October 14, 2010 – A bifurcation stent maker has closed $17 million in round D financing to help it expand worldwide, pursue research and development and seek out regulatory approvals in the United States, Japan and China. TriReme Medical announced the funding, which was led by Bio*One Capital.
October 14, 2010 – A new echocardiography management program has been launched with Blue Cross and Blue Shield of Vermont (BCBCVT). American Imaging Management (AIM) will partner with BCBSVT to support more consistent use of those services. AMI has provided diagnostic imaging clinical review services for Vermont health plans since 2008.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 13, 2010 – A new guidewire has been launched for use in challenging, small vessel peripheral angioplasty procedures. The Journey Guidewire, by Boston Scientific, is 0.014 inches and designed to address physician needs in treating arteries below the knee.
October 13, 2010 – A cardiac workstation software upgrade has been released that enables healthcare professionals to digitally store and review diagnostic test data. Version 1.6.3 of Welch Allyn’s CardioPerfect Workstation maximizes workflow efficiency and simplifies electronic health record (EHR) integration in ambulatory care settings that utilize thin-client technology.
October 13, 2010 – A recall was issued for bottles of 40 mg Lipitor, due to a small number of reports of an uncharacteristic odor related to the packaging. A medical assessment has determined that the odor is not likely to cause adverse health effects. However, Pfizer recommends that anyone taking 40 mg Lipitor who experiences a strange odor should return the tablets to their pharmacist.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 13, 2010 – The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it had cardiovascular safety risks. Sibutramine (Meridia), made by Abbott, is a prescription medicine used to help overweight or obese people lose weight. Abbott is voluntarily withdrawing the drug at the request of the U.S. Food and Drug Administration (FDA).
October 13, 2010 – Human trials commenced using a catheter guidance control and imaging (CGCI) system on patients with arrhythmias.
The Floor Post series of radiology workstations is designed to make the most of limited space by accommodating multiple ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 12, 2010 – A new collaborative Web portal brings a familiar user interface to the medical imaging world. Accelarad has updated its SeeMyRadiology.com portal to resemble LinkedIn and Facebook. The portal will be introduced at RSNA 2010.
October 8, 2010 — The Ivy Model 3000 Series Cardiac Trigger Monitor offers precision image-triggering nuclear medicine, computed tomography (CT) and magnetic resonance imaging (MRI) systems, with more than 16,000 different variations in use worldwide.
October 8, 2010 – Two new magnetic resonance imaging (MRI) scanners have received 510(k) FDA clearance and are now commercially available in the United States. The Siemens Magnetom Aera 1.5 Tesla and Magnetom Skyra 3T scanners are the first Tim 4G and DOT systems to receive U.S. clearance.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 8, 2010 – New data from the HORIZONS-AMI trial shows that administering the anticoagulant bivalirudin (Angiomax) enhances survival in heart attack patients undergoing angioplasty after three years. The results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium in Washington, D.C.
October 8, 2010 – New features in the 2.0 version of the Acuson S2000 ultrasound system released today cover the entire continuum of care for vascular and cardiac imaging.
October 7, 2010 – The Superior Court of Massachusetts has ruled against LightLab Imaging in the company’s optical coherence tomography (OCT) trade secret case against Volcano and its wholly owned subsidiary, Axsun Technologies. LightLab Imaging is a wholly owned subsidiary of St. Jude Medical.